Stigmatization and Resources Allocation-Ethical Dilemmas for HIV Positive Intravenous Drug Users
DOI:
https://doi.org/10.53685/jshmdc.v1i2.69Abstract
The burden of disease due to Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Pakistan is on the rise. According to an estimate approximately 0.165 million people in Pakistan are infected with HIV and 17,149 person are currently receiving treatment for HIV/AIDS. The prevalence of HIV is 20% for intravenous Drug Users (IVDUs) while national surveillance data shows rate of infection in most major cities in range of 15-50%. In light of such alarming figures, distribution of resources and stigmatization are two ethical issues that gain attention of not only healthcare providers but also patients. Following is a case with discussion on these ethical issues.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Sarosh Saleem, Maryam Riaz Tarar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
-
Non Commercial — You may not use the material for commercial purposes.
-
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a 
